equitymaster.comFalseFalseINDRAPRASTHA MEDICAL - Last 8 Quarters |
|
Interim Results |
| No. of Months
Qtr. Ending | 3
Mar-22* | 3
Jun-22* | 3
Sep-22* | 3
Dec-22* | 3
Mar-23* | 3
Jun-23* | 3
Sep-23* | 3
Dec-23* |
Net Sales | Rs m | 2,157 | 2,633 | 2,844 | 2,769 | 2,741 | 3,065 | 3,170 | 3,065 |
Other income | Rs m | 18 | 8 | 14 | 31 | 48 | 36 | 42 | 43 |
Turnover | Rs m | 2,176 | 2,641 | 2,858 | 2,800 | 2,788 | 3,101 | 3,212 | 3,107 |
Expenses | Rs m | 1,882 | 2,264 | 2,408 | 2,399 | 2,409 | 2,593 | 2,666 | 2,592 |
Gross profit | Rs m | 275 | 369 | 436 | 371 | 331 | 473 | 504 | 473 |
Depreciation | Rs m | 86 | 97 | 99 | 99 | 99 | 98 | 100 | 100 |
Interest | Rs m | 7 | 12 | 14 | 9 | 9 | 8 | 9 | 9 |
Profit before tax | Rs m | 200 | 268 | 338 | 294 | 272 | 402 | 437 | 407 |
Tax | Rs m | 48 | 65 | 86 | 85 | 74 | 97 | 108 | 112 |
Profit after tax | Rs m | 152 | 203 | 251 | 209 | 198 | 305 | 329 | 294 |
Gross profit margin | % | 12.8 | 14.0 | 15.3 | 13.4 | 12.1 | 15.4 | 15.9 | 15.4 |
Effective tax rate | % | 23.9 | 24.4 | 25.5 | 28.9 | 27.1 | 24.2 | 24.7 | 27.6 |
Net profit margin | % | 7.0 | 7.7 | 8.8 | 7.5 | 7.2 | 10.0 | 10.4 | 9.6 |
Diluted EPS | Rs | 1.7 | 2.2 | 2.7 | 2.3 | 2.2 | 3.3 | 3.6 | 3.2 |
Diluted EPS (TTM) | Rs | 6.4 | 6.9 | 8.3 | 8.9 | 9.4 | 10.5 | 11.4 | 12.3 |
* Results Consolidated | Source: Company Annual Reports, Regulatory Filings, Equitymaster |
Interim results exclude extraordinary / exceptional items |